Nuvation Bio Inc. (NUVB)
NYSE: NUVB · IEX Real-Time Price · USD
2.600
+0.020 (0.78%)
At close: Apr 19, 2024, 4:00 PM
2.680
+0.080 (3.08%)
After-hours: Apr 19, 2024, 7:39 PM EDT

Nuvation Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Selling, General & Admin
28.5331.9224.2810.956.99
Research & Development
71.2987.8269.0432.625.11
Operating Expenses
99.82119.7393.3243.5532.1
Operating Income
-99.82-119.73-93.32-43.55-32.1
Interest Expense / Income
00002.66
Other Expense / Income
-24.02-15.54-6.47-1.89-1.21
Pretax Income
-75.8-104.2-86.85-41.66-33.55
Net Income
-75.8-104.2-86.85-41.66-33.55
Shares Outstanding (Basic)
21921719898207
Shares Outstanding (Diluted)
21921719898207
Shares Change
1.00%9.52%102.90%-52.81%-
EPS (Basic)
-0.35-0.48-0.44-0.43-0.16
EPS (Diluted)
-0.35-0.48-0.44-0.43-0.16
Free Cash Flow
-68.05-96.47-68.47-36.67-25.09
Free Cash Flow Per Share
-0.31-0.45-0.35-0.38-0.12
EBITDA
-75.65-103.72-86.48-41.56-30.88
Depreciation & Amortization
0.160.480.370.10.01
EBIT
-75.8-104.2-86.85-41.66-30.89
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).